Usual Adult Dose for Chronic Obstructive Pulmonary Disease

• 5 mcg (2 inhalations) orally once a day

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

Mild to moderate liver dysfunction: No adjustment recommended.
Severe liver dysfunction: Data not available

Precautions

CONTRAINDICATIONS:

• Use of a long-acting beta-2 (LABA) agonist without an inhaled corticosteroid (ICS) in asthma patients; this drug is not indicated for asthma treatment

Dialysis

Data not available

Other Comments

Administration advice:

• Administer at the same time of the day.
• The recommended daily dose should not be exceeded.
• This drug is for oral inhalation only.
• To ensure proper use of the inhalation device, see Instructions for its use.

• This drug is not indicated to treat asthma or acute deterioration of COPD.

• Notify the physician immediately if experiencing any of the following: Worsening of symptoms; decreasing effectiveness of inhaled, short-acting beta2-agonists; need for more inhalations than usual of the inhaled, short-acting beta2-agonists; significant decrease in lung function as outlined by the physician.
• Therapy with this drug should not be stopped without physician/provider guidance since symptoms may recur after discontinuation.
• Discontinue previous regular use of short acting beta2-agonist and use them only for the symptomatic relief of acute symptoms.